Abstracts tagged "Anti-CCP antibodies and rheumatoid arthritis (RA)"

Abstract Number: 407 • 2013 ACR/ARHP Annual Meeting
Association Between Anti-Cyclic Citrullinated Peptide Antibodies Titres and The Presence and Severity Of Diffuse Interstitial Lung Disease Secondary To Rheumatoid Arthritis
Juan Manuel Ponce-Guarneros¹, Alberto Daniel Rocha Muñoz², Jorge Ivan Gámez Nava³, Soraya Amalí Zavaleta Muñíz⁴, Miriam Lizette Díaz Toscano⁵, Mario Salazar Paramo⁶, Liliana Faviola De La Cerda Trujillo⁷, Norma Guadalupe González Montoya³, Ernesto German Cardona Muñoz⁸, Monica Vazquez del Mercado⁹ and Laura González López¹⁰, ¹Medidina Interna-Reumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social. Guadalajara., Guadalajara, Jalisco, Mexico, ²Institute for Research in Rheumatology and Musculoskeletal System, Guadalajara, Jalisco, Mexico, ³Unidad de Investigación en Epidemiología Clínica, Hospital de Especialidades Centro Médico Nacional de Occidente., Guadalajara, Jalisco, Mexico, ⁴Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Jalisco, México, Mexico, ⁵Fisiología, Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico, ⁶Clinical Research Division, Instituto Mexicano Del SS, Guadalajara, Mexico, ⁷Unidad de Investigación en Epidemiología Clínica del Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico, ⁸Departamento de Fisiología, Universidad de Guadalajara, Guadalajara, México, Guadalajara, Jalisco, Mexico, ⁹Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, ¹⁰Medicina Interna-Reumatología, Departamento de Medicina Interna-Reumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social., Guadalajara, Jalisco, Mexico
Background/Purpose: To evaluate the association between anti-cyclic citrullinated peptide antibody titres (anti-CCP) and other clinical factors with the presence and severity of Interstitial Lung Disease…
Abstract Number: 1202 • 2012 ACR/ARHP Annual Meeting
Antibodies Against Porphyromonas Gingivalis Correlate with Rheumatoid Arthritis-Specific Auto-Immunity in Arthralgia Patients
M. J. de Smit¹, L. A. van de Stadt², J. Westra³, B. Doornbos-van der Meer³, K.M.J. Janssen⁴, A. Vissink⁵, A. J. van Winkelhoff⁶, E. Brouwer⁷ and Dirkjan van Schaardenburg⁸, ¹Center for Dentistry and Oral Hygiene, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ²Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, ³Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁴Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁵Oral and Maxillofacial Surgery, University of Groningen, University Medical Center, Groningen, Netherlands, ⁶Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁷Rheumatology and Clinical Immunology, University of Groningen, University Medical Center, Groningen, Netherlands, ⁸Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands
Background/Purpose: In the disease association between rheumatoid arthrtitis (RA) and periodontitis a potential role is suggested for the periodontal pathogen Porphyromonas gingivalis (PG). PG is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].